BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8459981)

  • 1. Commercialization of clinical genetic laboratory services: in whose best interest?
    Milunsky A
    Obstet Gynecol; 1993 Apr; 81(4):627-9. PubMed ID: 8459981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mycobacterial tests].
    Takashima T; Higuchi T
    Kekkaku; 2008 Jan; 83(1):43-59. PubMed ID: 18283915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing environment for single-gene disorders in U.S. reference laboratories.
    Amos J; Gold B
    Hum Mutat; 1998; 12(5):293-300. PubMed ID: 9792404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Traditional and innovative diagnostic tools: when and why they should be applied].
    Cancrini G; Iori A
    Parassitologia; 2004 Jun; 46(1-2):173-6. PubMed ID: 15305711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commercial molecular diagnostics in the U.S.: The Human Genome Project to the clinical laboratory.
    Amos J; Patnaik M
    Hum Mutat; 2002 Apr; 19(4):324-33. PubMed ID: 11933187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The link between providers and patients: how laboratories can ensure quality results with genetic testing.
    Quillin JM; Jackson-Cook C; Bodurtha J
    Clin Leadersh Manag Rev; 2003; 17(6):351-7. PubMed ID: 14692080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carrier screening for cystic fibrosis in US genetic testing laboratories: a survey of laboratory directors.
    Kaufman DJ; Katsanis SH; Javitt GH; Murphy JA; Scott JA; Hudson KL
    Clin Genet; 2008 Oct; 74(4):367-73. PubMed ID: 18700896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Considering what clinical laboratories should become in the future--POCT, mail testing and OTC test].
    Matsuo S
    Rinsho Byori; 2005 Dec; 53(12):1159-63. PubMed ID: 16447688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic testing: a physician's perspective.
    Menasha JD; Schechter C; Willner J
    Mt Sinai J Med; 2000 Mar; 67(2):144-51. PubMed ID: 10747371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Why medical consultation is needed in the clinical laboratory].
    Kawai T
    Rinsho Byori; 1998 Oct; 46(10):972-7. PubMed ID: 9816906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commercialization of genetic testing services: the FDA, market forces, and biological tarot cards.
    Malinowski MJ; Blatt RJ
    Tulane Law Rev; 1997 Mar; 71(4):1211-312. PubMed ID: 15744901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Scottish molecular genetics consortium--15 years on.
    Kelly KF
    Health Bull (Edinb); 2002 Jan; 60(1):83-90. PubMed ID: 12664773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A role of clinical pathologists in Laboratory Information (Consulting) Center].
    Shimetani N; Ohtani H
    Rinsho Byori; 1999 Oct; 47(10):926-32. PubMed ID: 10590666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Consultation services at the commercial laboratories].
    Samori T
    Rinsho Byori; 1997 Sep; 45(9):885-90. PubMed ID: 9311263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A framework for genetic service provision for haemophilia and other inherited bleeding disorders.
    Ludlam CA; Pasi KJ; Bolton-Maggs P; Collins PW; Cumming AM; Dolan G; Fryer A; Harrington C; Hill FG; Peake IR; Perry DJ; Skirton H; Smith M;
    Haemophilia; 2005 Mar; 11(2):145-63. PubMed ID: 15810917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies and logistical requirements for efficient testing in genetic disease.
    Jackson-Cook C; Pandya A
    Clin Lab Med; 1995 Dec; 15(4):839-57. PubMed ID: 8838226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic testing: considerations for pediatric nephrologists.
    Guay-Woodford LM; Knoers NV
    Semin Nephrol; 2009 Jul; 29(4):338-48. PubMed ID: 19615555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.